NCT02940067

Brief Summary

This is a pilot study to investigate the effect of prehabilitation on patients undergoing elective surgery for pancreatic disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable pancreatic-cancer

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable pancreatic-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 20, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

March 28, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2018

Completed
Last Updated

August 29, 2018

Status Verified

August 1, 2018

Enrollment Period

1.2 years

First QC Date

October 15, 2016

Last Update Submit

August 28, 2018

Conditions

Keywords

prehabilitationpancreatectomynutritionexercise

Outcome Measures

Primary Outcomes (1)

  • Peak power - measured using cardiopulmonary exercise testing

    cardiopulmonary fitness

    Change in peak power between start and end of prehabilitation (4 weeks)

Secondary Outcomes (6)

  • Insulin sensitivity - measured using the insulin clamp test

    Change in insulin sensitivity between start and end of prehabilitation (4 weeks)

  • Length of stay

    From date of operation until date of discharge

  • Complication rate

    From date of operation until date of discharge

  • Sleep

    Change in sleep quality between start and end of prehabilitation (4 weeks)

  • Fatigue

    Change in fatigue levels between start and end of prehabilitation (4 weeks)

  • +1 more secondary outcomes

Study Arms (2)

MedEx

EXPERIMENTAL

This group will receive nutritional supplementation (based on components of the MEDiterranean diet) and supervised EXercise training for four weeks - hence the trial name, MedEx.

Other: MedEx

Standard Care

NO INTERVENTION

This group will follow current standard preoperative care before scheduled pancreatic resection.

Interventions

MedExOTHER

A combination of dietary and exercise interventions over four weeks before scheduled pancreatic surgery

Also known as: Prehabilitation
MedEx

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective pancreatic resection

You may not qualify if:

  • Contraindication to cardiopulmonary exercise testing: unstable cardiac disease, lower limb dysfunction Emergency surgery Ischaemic ECG during cardiopulmonary exercise test Allergy to fish oil or olive oil

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MATTU, Royal Surrey County Hospital

Guildford, Surrey, GU2 7WG, United Kingdom

Location

Related Publications (3)

  • Dunne DF, Jack S, Jones RP, Jones L, Lythgoe DT, Malik HZ, Poston GJ, Palmer DH, Fenwick SW. Randomized clinical trial of prehabilitation before planned liver resection. Br J Surg. 2016 Apr;103(5):504-12. doi: 10.1002/bjs.10096. Epub 2016 Feb 11.

    PMID: 26864728BACKGROUND
  • Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab. 2010 Sep;95(9):4338-44. doi: 10.1210/jc.2010-0135. Epub 2010 Jul 14.

    PMID: 20631016BACKGROUND
  • Snowden CP, Prentis JM, Anderson HL, Roberts DR, Randles D, Renton M, Manas DM. Submaximal cardiopulmonary exercise testing predicts complications and hospital length of stay in patients undergoing major elective surgery. Ann Surg. 2010 Mar;251(3):535-41. doi: 10.1097/SLA.0b013e3181cf811d.

    PMID: 20134313BACKGROUND

MeSH Terms

Conditions

Pancreatic NeoplasmsPancreatitis, ChronicMotor Activity

Interventions

Preoperative Exercise

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesPancreatitisChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Perioperative CarePatient CareTherapeuticsSurgical Procedures, OperativeExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Tim Rockall, MD FRCS

    MATTU, Royal Surrey County Hospital, Guildford, Surrey

    STUDY CHAIR
  • Mike Scott, FRCA FFICM

    MATTU, Royal Surrey County Hospital, Guildford, Surrey

    STUDY DIRECTOR
  • Jason George, MA MRCS

    MATTU, Royal Surrey County Hospital, Guildford, Surrey

    PRINCIPAL INVESTIGATOR
  • Martin Whyte, PhD FRCP

    University of Surrey, Guildford, Surrey

    STUDY DIRECTOR
  • Joe Wainwright, BSc

    University of Surrey and Surrey Human Performance Institute

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Fellow

Study Record Dates

First Submitted

October 15, 2016

First Posted

October 20, 2016

Study Start

March 28, 2017

Primary Completion

June 21, 2018

Study Completion

August 20, 2018

Last Updated

August 29, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations